Skip to main content


Figure 2 | BMC Infectious Diseases

Figure 2

From: Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults

Figure 2

Hemagglutination-inhibition antibody Geometric Mean Titers after primary vaccination and heterologous booster vaccination at Month 6 in the per-protocol immunogenicity cohort. †Pre-vaccination values; CI, confidence interval; GMT, geometric mean titer. Subjects in the AS03-H5N1 primary vaccine group received one dose of heterologous booster at Month 6; Subjects in the non-adjuvanted-H5N1 primary vaccine group received two doses of heterologous booster at Month 6, given 21 days apart.

Back to article page